| Sahar Halabi, MD | |
|
761 45th St Ste 108, Munster, IN 46321-2899 | |
| (219) 922-5416 | |
| (219) 922-3745 |
| Full Name | Sahar Halabi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 761 45th St Ste 108, Munster, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003937350 | NPI | - | NPPES |
| 364322170 | Other | IL | TID |
| 1003937350 | Other | IL | NPI |
| 200265904 | Other | IL | TID |
| Entity Name | Pekin Prohealth Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932150299 PECOS PAC ID: 1951214576 Enrollment ID: O20031110000647 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Methodist Medical Center Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982656575 PECOS PAC ID: 1355259714 Enrollment ID: O20031126000494 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Decatur Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164477725 PECOS PAC ID: 6204731144 Enrollment ID: O20031203000685 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Good Samaritan Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487758801 PECOS PAC ID: 1658272059 Enrollment ID: O20040119000325 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Sigma Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720035843 PECOS PAC ID: 2961305693 Enrollment ID: O20040130000006 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Proctor Health Systems |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134173917 PECOS PAC ID: 3476440173 Enrollment ID: O20040227000906 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Southern Illinois Medical Services Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770656837 PECOS PAC ID: 3678677390 Enrollment ID: O20070404000595 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Entity Name | Cep America Illinois Intensivists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821641499 PECOS PAC ID: 0345535449 Enrollment ID: O20160829002157 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sahar Halabi, MD Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Sahar Halabi, MD 761 45th St Ste 108, Munster, IN 46321-2899 Ph: (219) 922-5416 |
News Archive
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.'s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow's treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
A UCLA study reveals how human genes interact with their environment to boost disease risk. Published in the Feb. 18 online edition of the American Journal of Human Genetics, the findings shed light on why the search for specific gene variants linked to human diseases can only partly explain common disorders.
The United States will need about 52,000 new primary-care doctors as the population grows and ages, according to a new study. Research published in the Annals of Family Medicine estimated that most of the doctor shortage will be caused by the rising U.S. population.
› Verified 1 days ago
Wassim Shwaiki, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 8840 Calumet Ave Ste 203, Munster, IN 46321 Phone: 219-836-7723 Fax: 219-836-7726 | |
Thottathil Viswanathan Gopan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 761 45th St Ste 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Kyle Kleist, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Superior Ave, Munster, IN 46321 Phone: 219-924-1300 Fax: 219-933-2288 | |
Dr. Gene Lee Chang, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9030 Columbia Ave, Munster, IN 46321 Phone: 219-836-6002 Fax: 219-836-6003 | |
Sana Shoaib Meah, D.O Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 761 45th Avenue, Suite 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Jay C. L.. Paik, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Macarthur Blvd, #15, Munster, IN 46321 Phone: 219-836-6411 Fax: 219-836-6415 |